Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. LEGN
LEGN logo

LEGN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LEGN News

Stock Futures Rise Modestly; Rumble and Others Show Strong Performance

2d agoseekingalpha

Legend Biotech Prices Public Offering of 7.7M ADSs

2d agoseekingalpha

Legend Biotech Prices Public Offering at $29.35 per ADS

3d agoNASDAQ.COM

Legend Biotech Prices Public Offering of ADSs

3d agoNewsfilter

Legend Biotech Launches $225 Million Public Offering of ADS

3d agoseekingalpha

Legend Biotech Launches $225 Million Public Offering

3d agoNewsfilter

LB2501 Shows Significant Efficacy in B-NHL Patients

6d agoNewsfilter

Legend Biotech's LB2501 Shows Promising Data for Lymphoma Treatment

Jun 03 2026NASDAQ.COM

Bluejay Diagnostics Partners with Argonaut, Shares Surge 100%

Jun 03 2026NASDAQ.COM

Promising Phase 1 Data for LB2501 CAR-T Therapy

Jun 02 2026Newsfilter

Legend Biotech Announces Phase 1 Results for LB2102 in Lung Cancer

Jun 02 2026NASDAQ.COM

LB2102 Shows Promising Clinical Activity in Small Cell Lung Cancer Trials

Jun 01 2026Newsfilter

Legend Biotech Presents Preliminary Data for LB2102 at ASCO Meeting

May 21 2026Newsfilter

First Beijing Investment Acquires Stake in Legend Biotech

May 17 2026Fool

First Beijing Investment Acquires Stake in Legend Biotech

May 17 2026Yahoo Finance

Legend Biotech Q1 Earnings Beat Expectations Despite Revenue Miss

May 12 2026seekingalpha